Glioblastoma: open trials in Austria

• 2023-506998-35-00

  Phase III trial of lomustine/temozolomide (TMZ) combination therapy vs. standard TMZ therapy for newly diagnosed MGMT promoter methylated glioblastoma (IDHwt) patients +/- tumor treating fields (Optune)

  Trial Treatment · Phase 3 · Vaestra Goetalandsregionen

  Medical University of Graz, Graz · Medizinische Universitaet Innsbruck, Innsbruck · Johannes Kepler University Linz, Linz · Noe LGA Gesundheit Region Mitte GmbH, St. Poelten

  Registry updated 2026-08-27

• NCT07100730

  Study of TLX101-Tx Plus Standard of Care (SoC) Versus SoC Alone for the Treatment of Patients With Recurrent Glioblastoma

  Trial Treatment · Phase 3 · Telix Pharmaceuticals (Innovations) Pty Limited

  Johannes Kepler University, Linz

  Registry updated 2026-08-11

• 2025-524299-44-00

  First study evaluating the safety and dosage of YG-01 in patients with a malignant brain tumor

  Trial Treatment · Phase 1 · Ygion Biomedical GmbH

  Medical University of Vienna, Vienna

  Registry updated 2026-06-29

• NCT05904119

  Lomustine With and Without Reirradiation for First Progression of Glioblastoma: a Randomized Phase III Study

  Trial Treatment · Phase 3 · European Organisation for Research and Treatment of Cancer - EORTC

  Medizinische Universitaet Innsbruck, Innsbruck · Kepler Universitaetsklinikum GmbH, Linz · Medical University of Vienna, Vienna

  Registry updated 2026-06-08

• NCT07627334

  Personalized Targeted Glioblastoma Therapies by ex Vivo Drug Screening: Advanced Brain Tumor TheRApy Clinical Trial In Patients Scheduled for shOrt Course radiatioN

  Trial Treatment · Medical University of Vienna

  AKH Vienna, Department for Internal Medicine I, Oncology, Vienna

  Registry updated 2026-06-04

• NCT06512311

  Personalized Targeted Glioblastoma Therapies by ex Vivo Drug Screening

  Trial Treatment · Medical University of Vienna

  AKH Vienna, Department for Internal Medicine I, Oncology, Vienna

  Registry updated 2026-04-14

• NCT06419946

  Lomustine in Addition to Standard of Care in Patients With MGMT Methylated Glioblastoma

  Trial Treatment · Phase 3 · Vastra Gotaland Region

  University Hospital Graz, Graz · Medizinische Universität Innsbruck, Innsbruck · Kepler University Hospital, Linz · University Hospital St. Pölten, Sankt Pölten

  Registry updated 2026-04-13

• NCT02394626

  Surgery for Recurrent Glioblastoma

  Trial Treatment · Phase 2 · Insel Gruppe AG, University Hospital Bern

  Universitätsklinikum Innsbruck, Innsbruck · Johannes Kepler University Linz University, Clinic for Neurosurgery, Linz · Medical University of Vienna, Department of Neurosurgery, Vienna

  Registry updated 2026-02-02

All Glioblastoma trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error